Evidence map›Paper›PMID 36927955›Full record

ArticleJCI insight2023

Loss-of-function variant in SPIN4 causes an X-linked overgrowth syndrome.

Julian C Lui, Jacob Wagner, Elaine Zhou, Lijin Dong, Kevin M Barnes, Youn Hee Jee, Jeffrey Baron

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Clinical Observation of a Rare Binder Phenotype With Fetal Overgrowth Due to aMaternal-fetal medicine (Wolters Kluwer Health, Inc.) · 2025
    Article
  7. The genetic basis of human height.Nature reviews. Genetics · 2025
    Review
  8. Article
  9. Epigenetic Causes of Overgrowth Syndromes.The Journal of clinical endocrinology and metabolism · 2024
    Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Julian C LuiSection on Growth and Development, Eunice Kennedy Shriver National Institute of Child Health and Human Development, and.
Jacob WagnerSection on Growth and Development, Eunice Kennedy Shriver National Institute of Child Health and Human Development, and.
Elaine ZhouSection on Growth and Development, Eunice Kennedy Shriver National Institute of Child Health and Human Development, and.
Lijin DongGenetic Engineering Core, National Eye Institute, National Institute of Health, Bethesda, Maryland, USA.
Kevin M BarnesSection on Growth and Development, Eunice Kennedy Shriver National Institute of Child Health and Human Development, and.
Youn Hee JeeSection on Growth and Development, Eunice Kennedy Shriver National Institute of Child Health and Human Development, and.
Jeffrey BaronSection on Growth and Development, Eunice Kennedy Shriver National Institute of Child Health and Human Development, and.
Eunice Kennedy Shriver National Institute of Child Health and Human Development · USNational Eye Institute · US

Funding

Regulation Of Childhood GrowthZIAHD000640 · NICHD · EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT · PI BARON, JEFFREY · 2009 to 2025
$24.4M
NEI Genetic Engineering CoreZICEY000458 · NEI · NATIONAL EYE INSTITUTE · PI DONG, LIJIN · 2009 to 2025
$22.6M
Intramural NIH HHS ZIA HD000640
6 · The paper itself

Abstract

Overgrowth syndromes can be caused by pathogenic genetic variants in epigenetic writers, such as DNA and histone methyltransferases. However, no overgrowth disorder has previously been ascribed to variants in a gene that acts primarily as an epigenetic reader. Here, we studied a male individual with generalized overgrowth of prenatal onset. Exome sequencing identified a hemizygous frameshift variant in Spindlin 4 (SPIN4), with X-linked inheritance. We found evidence that SPIN4 binds specific histone modifications, promotes canonical WNT signaling, and inhibits cell proliferation in vitro and that the identified frameshift variant had lost all of these functions. Ablation of Spin4 in mice recapitulated the human phenotype with generalized overgrowth, including increased longitudinal bone growth. Growth plate analysis revealed increased cell proliferation in the proliferative zone and an increased number of progenitor chondrocytes in the resting zone. We also found evidence of decreased canonical Wnt signaling in growth plate chondrocytes, providing a potential explanation for the increased number of resting zone chondrocytes. Taken together, our findings provide strong evidence that SPIN4 is an epigenetic reader that negatively regulates mammalian body growth and that loss of SPIN4 causes an overgrowth syndrome in humans, expanding our knowledge of the epigenetic regulation of human growth.

Indexed as

Epigenesis, GeneticGenes, X-LinkedAnimalsCell Cycle ProteinsHumansMaleMammalsMiceMicrotubule-Associated ProteinsPhosphoproteinsSyndromeCell Cycle ProteinsMicrotubule-Associated ProteinsPhosphoproteinsspindlinBone developmentDevelopmentEpigeneticsGenetic diseasesGenetics

Identifiers

PMID36927955
PMCPMC10243798
OpenAlexW4327575200

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.